Human induced pluripotent stem cells (iPSCs) have transformed biomedical research, disease modeling, and regenerative medicine. Their capacity for indefinite self-renewal and differentiation into nearly any cell type offers unprecedented experimental power. However, that power is fully realized only when the cells are cultured under optimal conditions. Suboptimal culture practices lead to spontaneous differentiation, loss of pluripotency, genetic instability, and inconsistent experimental results. This article provides a comprehensive, best-practice guide for culturing human iPSCs, covering every stage from thawing to cryopreservation, with emphasis on reproducibility and cell health.

Establishing the Culture Environment

The physical environment in which iPSCs are grown directly influences their behavior. Use a sterile, humidified CO₂ incubator maintained at 37°C ± 0.5°C with 5% CO₂ and 95% relative humidity. Even small temperature fluctuations can trigger stress responses that compromise pluripotency. Calibrate your incubator regularly and place a backup temperature probe inside the chamber for continuous monitoring. High humidity prevents evaporation of culture medium, which otherwise would alter osmolarity and growth factor concentrations. Work always inside a certified Class II biological safety cabinet (BSC) to maintain sterility. Disinfect the BSC before and after use, and allow at least 15 minutes of airflow stabilization before handling cells.

Selecting Culture Medium and Supplements

Human iPSCs require a defined, serum-free medium that supplies essential nutrients and signaling molecules to sustain self-renewal while suppressing differentiation. Several commercial media are validated for feeder-independent culture: E8™ (STEMCELL Technologies), mTeSR™ Plus, and StemFlex™ (Gibco) are widely used. Each formulation is optimized for specific coating surfaces (see next section). E8 medium, for example, contains only eight components including bFGF and insulin, and is compatible with vitronectin-coated surfaces. mTeSR Plus is designed for higher clonal recovery and includes a proprietary supplement cocktail.

Always use medium within its expiration date and avoid repeated freeze-thaw cycles of supplements. Prewarm medium to 37°C immediately before feeding and change medium daily (some high-density cultures may require twice-daily feeding). Adding a ROCK inhibitor (e.g., Y-27632 at 10 µM) during the first 24 hours after thawing or passaging significantly improves single-cell survival.

Quality Control of Media and Supplements

Batch-to-batch variability in animal-derived components (e.g., bovine serum albumin) can affect pluripotency. Use media that are fully defined and xeno-free whenever possible, especially if the iPSCs are intended for downstream clinical applications. Verify each new lot of medium with a side-by-side culture test against your existing lot; monitor morphology, viability, and marker expression over at least two passages.

Substrate and Coating Options

iPSCs are anchorage-dependent and require an extracellular matrix (ECM) substrate to adhere, spread, and maintain the undifferentiated state. The most commonly used substrates include:

  • Matrigel® (Corning): A basement membrane extract from Engelbreth-Holm-Swarm mouse sarcoma cells. Rich in laminin, collagen IV, and entactin. Supports strong adhesion and robust pluripotency. However, batch variability and animal-derived components make it less suitable for xeno-free workflows.
  • Recombinant Vitronectin (VTN-N): A human recombinant fragment. Fully defined, xeno-free, and compatible with E8 medium. Provides consistent performance across batches. Coating at 0.5 µg/cm² is typical; incubate for 1 hour at room temperature.
  • Laminin-521 (Biolamina): A defined human recombinant laminin isoform. Excellent for both maintenance and differentiation protocols. Supports single-cell passaging with high survival rates.
  • Synthetic coatings (e.g., Synthemax® II): Chemically defined, animal-free, and provide stable, scalable surfaces. Particularly useful for large-scale expansion in bioreactors.

Regardless of the substrate, follow the manufacturer’s recommended dilution, incubation time, and storage conditions. Coat plates immediately before use or prepare pre-coated plates stored at 2–8°C for up to one week. After incubation, rinse the plate gently with PBS or DPBS to remove any unbound coating before seeding cells.

Thawing iPSCs

Thawing iPSCs correctly is critical to recover high viability after cryopreservation. Use a cryovial thawed rapidly in a 37°C water bath by gentle agitation until a small ice crystal remains. Immediately transfer the contents into 9 mL of pre-warmed complete medium containing a ROCK inhibitor (10 µM). Centrifuge at 200–300 × g for 5 minutes at room temperature. Aspirate the supernatant carefully without disturbing the cell pellet, then resuspend the pellet in fresh medium with ROCK inhibitor. Count viable cells using trypan blue exclusion and seed at a density of 100,000–200,000 viable cells per well of a 6-well plate (depending on the substrate and line). After 24 hours, replace the medium with fresh medium without ROCK inhibitor. Monitor attachment and morphology daily; some adaptation may require one to two passages before the culture stabilizes.

Passaging and Expansion

Routine passaging preserves the balance between confluency and pluripotency. Passage when colonies reach 70–80% confluence, typically every 4–7 days. At higher density, cells begin to differentiate spontaneously, especially along ectodermal lineages. Two main methods are used:

Enzymatic Passaging

Use gentle, recombinant dissociation reagents such as Accutase® or TrypLE™ Express. Remove the culture medium, rinse once with PBS (no Ca²⁺/Mg²⁺), then add pre-warmed dissociation reagent. Incubate for 2–5 minutes at 37°C until colony edges begin to lift and cells appear rounded. Do not over-digest, as that reduces viability. Gently tap the plate or triturate the cells 2–3 times with a pipette to break clumps into single cells or small clusters. Neutralize with an equal volume of medium containing ROCK inhibitor, centrifuge, and resuspend. Seed at ratios typically between 1:3 and 1:6, depending on the cell line and culture system. A ROCK inhibitor is strongly recommended for the first 24 hours to enhance survival of single cells.

Mechanical Passaging (for Sensitive Lines)

Some iPSC lines do not tolerate complete dissociation into single cells. For these, use a sterile needle or a StemPro® EZPassage™ tool to score colonies into uniform squares. Gently lift the pieces and transfer to a fresh coated plate. This method yields small clumps that reattach quickly but is more labor-intensive and less suited for large-scale expansion.

Importance of ROCK Inhibitor

The Rho-associated kinase (ROCK) inhibitor Y-27632 significantly reduces dissociation-induced apoptosis in human pluripotent stem cells. Add it to the medium at 10 µM for the first 24 hours after passaging or thawing. Remove it in subsequent feeds to avoid long-term inhibition of proliferation or subtle effects on differentiation potential.

Cryopreservation

Preserving master stocks and working banks of well-characterized iPSCs is essential for long-term studies. Use a cryopreservation medium that is defined and optimized for human pluripotent stem cells. Commercial options include CryoStor® CS10 or STEM-CELLBANKER®. Alternatively, formulate your own using 90% fetal bovine serum (FBS) and 10% DMSO, but note that this is not defined and not recommended if xeno-free conditions are required.

Harvest cells at 70–80% confluence using the same dissociation method as for passaging. Count the cells and resuspend at 1–2 × 10⁶ viable cells per 1 mL of cold cryopreservation medium. Aliquot into cryovials and transfer to a controlled-rate freezing container (e.g., Mr. Frosty™) placed in a –80°C freezer overnight. For long-term storage, transfer vials to liquid nitrogen (–196°C) within 24 hours. Avoid storage at –80°C for extended periods (more than a few days) as cellular viability declines. Maintain detailed inventory records with passage number, date, line identification, and any quality control results.

Monitoring Pluripotency and Quality Control

Even with perfect culture conditions, iPSCs can drift or differentiate over time. Regular monitoring is non-negotiable. Key quality control steps include:

  • Morphology: Healthy undifferentiated iPSC colonies appear as tightly packed, flat or slightly dome-shaped groups of small cells with high nucleus-to-cytoplasm ratio and prominent nucleoli. Differentiated cells often appear as larger, flattened cells with vacuolated cytoplasm or as elongated fibroblast-like cells at colony edges.
  • Pluripotency Marker Expression: Use immunofluorescence or flow cytometry to detect nuclear markers (OCT4, NANOG, SOX2) and surface markers (SSEA-3, SSEA-4, TRA-1-60, TRA-1-81). For routine monitoring, a monthly flow cytometry panel covering OCT4 and SSEA-4 is recommended. Gene expression analysis via qRT-PCR can detect early differentiation before morphological changes.
  • Karyotyping: Perform G-banding or SNP array karyotyping every 10–15 passages or whenever you observe abnormal growth. Common acquired abnormalities include trisomies of chromosomes 12, 17, and 20. Karyotyping is critical before using iPSCs in any high-stakes experiment or clinical application.
  • Mycoplasma Detection: Test cultures monthly using PCR-based or luminescence-based assays. Mycoplasma infection can alter gene expression, differentiation capacity, and growth rates without visible signs. Quarantine any positive cultures immediately and treat with BM-Cyclin® or discard.
  • Sterility Testing: Screen for bacterial and fungal contamination by inoculating culture supernatant into standard microbiological media (TSB, SCD) and incubating at 30–35°C for 14 days.

Troubleshooting Common Issues

Even experienced labs encounter problems. The table below summarizes frequent issues and solutions, but general principles apply: check the media, substrate, and incubator first.

Spontaneous Differentiation

Often caused by over-confluency, expired growth factors, or use of the wrong coating. Passage more frequently, use fresh bFGF, and verify that the medium contains the correct supplement concentration. Some lines are inherently prone to differentiation; consider switching to a medium designed for higher stability (e.g., StemFlex).

Low Cell Viability After Passaging

Check that the ROCK inhibitor was added at the correct concentration and that the dissociation time was not excessive. Also ensure the coating is fresh and fully covering the plate surface. If viability remains low (<50%), switch to a clump-passing method instead of single-cell dissociation.

Bacterial or Fungal Contamination

Immediately discard the entire culture plate. Disinfect the incubator and BSC thoroughly. Review aseptic technique with all personnel. Consider adding an antibiotic decontamination step (e.g., 1× Primocin™) to medium for one passage after rescue, but be aware that antibiotics can mask contamination and may affect cell behavior. Always confirm sterility before returning to antibiotic-free medium.

Slow Growth or Poor Colony Formation

Possible causes include low-density seeding, suboptimal coating, or medium that has lost activity. Verify seed density and ensure the medium is pre-warmed and used within 24 hours of adding bFGF. Some lines have intrinsic slower growth; adjust passage ratio and feeding schedule accordingly.

Conclusion

Successful human iPSC culture hinges on meticulous attention to every detail: the incubator environment, medium formulation, substrate choice, passaging technique, and ongoing quality control. Consistently following evidence-based best practices not only preserves pluripotency but also ensures that experimental results are reproducible and biologically meaningful. For further reading, consult resources from STEMCELL Technologies, the Thermo Fisher Scientific iPSC Culture Hub, and ATCC guidelines for iPSC culture. By adopting these protocols, researchers can maximize the potential of human iPSCs for cutting-edge science and translational applications.